Surface Plasmon Resonance (SPR) and MALDI Mass Spectrometry for Primary (HTS) and Secondary Screening.
The webinar gives and update on the latest developments in MALDI mass spectrometry for high-throughput screening and CPD profiling (rapifleX MALDI PharmaPulse) and introduce Bruker's new surface plasmon resonance (SPR) instrument, the SIERRA SPR-32.
Run time: 55:24 mins
Label-free techniques for Drug Discovery
Video Credit: Bruker Life Sciences Mass Spectrometry